Eugene Durenard - Nov 23, 2022 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)

Role: Director
Signature: /s/ Eugene Durenard
Stock symbol: CODX
Transactions as of: Nov 23, 2022
Transactions value $: $0
Form type: 4
Date filed: 11/23/2022, 09:58 AM
Previous filing: Jul 12, 2022
Next filing: Jan 9, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CODX	Common Stock	Award	$0	+11.7K	+93.34%	$0.00	24.2K	Nov 23, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CODX	Restricted Stock Units	Options Exercise	$0	-11.7K	-14.14%	$0.00	70.8K	Nov 23, 2022	Common Stock	82.5K	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Included in 37,500 restricted stock units awarded to the Reporting Person on January 8, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in three equal installments every twelve months commencing on January 8, 2021. Included in 70,000 restricted stock units awarded to the Reporting Person on July 11, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2022.

Content

Included in 37,500 restricted stock units awarded to the Reporting Person on January 8, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in three equal installments every twelve months commencing on January 8, 2021. Included in 70,000 restricted stock units awarded to the Reporting Person on July 11, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2022.